Insights

atai Life Sciences Reveals Promising Results from EMP-01 Phase 1 Study

NEW YORK- atai Life Sciences, a clinical-stage biopharmaceutical company, has announced encouraging results from its Phase 1 study of EMP-01, an orally administered R-enantiomer of MDMA. This study, a significant step in the company's mission to revolutionize mental health treatment, was designed to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EMP-01. The ...

January 2nd, 2024|

Oakland Tragedy Highlights Urgent Need for Federal Cannabis Policy Reform

LOS ANGELES- A somber mood envelops the Oakland Police Department following the tragic death of Officer Tuan Le, who was fatally shot while responding to a burglary at a cannabis dispensary. The incident underscores a pressing national issue: the impact of federal inaction on cannabis policy, which significantly elevates risks for dispensary workers, the public, ...

January 2nd, 2024|

Virginia’s Legislative Shift: A New Hope for Adult-Use Cannabis Sales

NEW YORK-  The political landscape in Virginia is undergoing a significant transformation as Democrats regain full control of the General Assembly, bringing renewed optimism for the launch of an adult-use cannabis market. This development comes with high expectations, as projections suggest the market could exceed $1 billion in sales within a few years, positioning Virginia ...

January 2nd, 2024|

Alberta Introduces Progressive Cannabis Regulations to Boost Market and Consumer Access

LOS ANGELES- In a landmark move, Alberta, Canada, has announced new regulations set to invigorate the cannabis industry within the province, signaling a significant shift in the landscape of legal cannabis since its nationwide legalization in 2018. These regulations, poised to take effect on January 31, 2024, are expected to enhance both retailer flexibility and ...

January 1st, 2024|

Australia’s First Psychedelic-Assisted Therapy Clinic Receives Key Endorsement, Paving Way for Innovative Mental Health Treatments

NEW YORK- In a significant milestone for mental healthcare in Australia, Incannex Healthcare Ltd's subsidiary, Clarion Clinics, has received the Human Research Ethics Committee (HREC) endorsement for its pioneering psychedelic-assisted therapy clinic in Melbourne. This endorsement represents a crucial step in the administration of psychedelic drugs for therapeutic purposes in Australia, especially for conditions like ...

January 1st, 2024|
  • Cannabis in Food and Beverage, Cannabis Extraction Market

Pennsylvania Advances Fair Competition in Medical Cannabis with SB 773

NEW YORK- Governor Josh Shapiro has signed into law SB 773, a bill poised to revolutionize Pennsylvania's medical cannabis market by promoting fair competition and challenging the dominance of major multistate operators (MSOs). This legislation represents a significant shift from the existing constraints that have hindered the growth of small and medium-sized businesses in the ...

December 28th, 2023|

Missouri’s Cannabis Microbusiness License Program Under Scrutiny Amid Ineligibility and Exploitation Concerns

NEW YORK– Missouri's well-intentioned microbusiness license program, designed to foster diversity and inclusion in the burgeoning cannabis industry, is now facing significant scrutiny. Recent findings have revealed a disturbing trend of ineligible applicants receiving licenses, and out-of-state companies exploiting the system, casting a shadow over the program's integrity and fairness. Established in November 2022 as ...

December 27th, 2023|

Massachusetts Eases ‘Two Agent Rule’ for Cannabis Deliveries, Boosting Industry Efficiency

LOS ANGELES- In a significant development for the cannabis industry in Massachusetts, the state's Cannabis Control Commission (CCC) has voted to amend the longstanding "Two Agent Rule" for cannabis deliveries. This decision marks a pivotal change for delivery companies in the state, reducing operational costs and increasing efficiency. The "Two Agent Rule," which mandated two ...

December 26th, 2023|

Global Recreational Cannabis Market on Track to Reach $50 Billion by 2027, Report Finds

LOS ANGELES- In a significant development for the global cannabis industry, a recent report from Prohibition Partners, a leading U.K.-based cannabis data, media, and technology firm, projects a dramatic expansion in the worldwide market for legal adult-use cannabis. The report estimates that by 2027, global sales will nearly double, reaching around $50 billion, driven largely ...

December 26th, 2023|

Revive Therapeutics Ltd. Announces Key Decisions and Appointments at Annual Shareholders Meeting

LOS ANGELES- Revive Therapeutics Ltd., a specialty life sciences company, held its annual general and special meeting of shareholders on Tuesday, December 19, 2023, in Toronto, Ontario. The meeting concluded with significant decisions affecting the company's future trajectory. Unanimous Support for Key Resolutions During the meeting, shareholders overwhelmingly supported all the proposals outlined in the ...

December 26th, 2023|

Decade of Discovery, Cannabis Studies Amid Legalization

NEW YORK— A significant surge in scientific research related to cannabis has been noted in the past ten years, coinciding with widespread legalization movements across the United States. This trend was highlighted by NORML, a cannabis advocacy group, which reported an extraordinary increase in the volume of peer-reviewed scientific papers on the subject. According to ...

December 25th, 2023|

Incannex’s Subsidiary Clarion Clinics Gains Ethics Endorsement for Psychedelic-Assisted Therapies

LOS ANGELES- Incannex Healthcare Ltd  a clinical stage pharmaceutical development company, has announced a significant advancement in the field of psychedelic-assisted therapies. Its subsidiary, Clarion Clinics, received Human Research Ethics Committee (HREC) endorsement for administering psychedelic-assisted therapies for Treatment Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD). This approval marks a critical step in legitimizing ...

December 25th, 2023|

Mydecine Innovations Group Announces Major Patent Progress for Novel Psilocin Analog

LOS ANGELES-  Mydecine Innovations Group Inc, a biotechnology company in mental health and addiction treatment, has recently announced a significant breakthrough. The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's MYCO-005 compound, titled “Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same Unique Compound (US20230348380A1)”. This ...

December 25th, 2023|
  • Recreational Cannabis

Colorado Voter Initiative Challenges Federal Law on Cannabis Users’ Gun Rights

LOS ANGELES- A new voter initiative in Colorado is stirring up a significant debate over the intersection of cannabis legalization and gun rights. The proposal, spearheaded by the pro-gun advocacy group Guns for Everyone, aims to allow cannabis consumers to qualify for concealed carry firearm permits, challenging the current restrictions imposed by federal law. Under ...

December 22nd, 2023|

Controversy Arises Over Ohio’s New Cannabis Control Superintendent Appointment

LOS ANGELES- Ohio's recent strides towards cannabis legalization have been met with a mix of anticipation and concern, particularly following the appointment of James V. Canepa as the first Superintendent of the Division of Cannabis Control. This decision has sparked debate among industry experts, activists, and the public, raising questions about the state's commitment to progressive ...

December 22nd, 2023|

Minnesota Health Officials Caution Against Illegal High-Potency Hemp Products

LOS ANGELES- The Minnesota Department of Health has issued an urgent warning to consumers regarding the sale of unregulated and illegal cannabis products that exceed the state's THC potency limits. Despite legalizing recreational cannabis earlier this year, Minnesota does not expect state-licensed cannabis dispensaries to open until possibly early 2025, leaving a regulatory gap that ...

December 22nd, 2023|

California Attorney General Warns of Federal Risks in Interstate Cannabis Commerce

LOS ANGELES- California Attorney General Rob Bonta has recently raised significant concerns over the potential federal legal risks involved in initiating interstate cannabis commerce. This issue has become a pivotal point of discussion following the enactment of a law by Gov. Gavin Newsome last year, which authorized state-licensed cannabis companies to export their products to ...

December 22nd, 2023|

Psychedelics Regulatory Maze: Navigating the State-Federal Conundrum

The expanding legalization of psychedelics for medical and therapeutic uses across various states in the United States is stepping into a complex regulatory terrain, one previously charted by the cannabis industry. This emerging scenario raises critical questions about the interplay between state autonomy and federal oversight in drug regulation. The issue hinges on the divergent ...

December 20th, 2023|

Numinus and Cedar Clinical Research Join Beckley Psytech’s Phase 2b Psychedelic Trial for Depression

Numinus Wellness Inc. recognized for approach to mental health care, has announced a significant milestone in psychedelic-assisted therapies. Its research arm, Cedar Clinical Research (CCR), has been selected as a pivotal site for a groundbreaking Phase 2b clinical trial by Beckley Psytech, focusing on Treatment Resistant Depression (TRD). This study is designed to assess the ...

December 19th, 2023|

Regulatory Hurdles Challenge Social Equity Cannabis Licensing in Missouri

LOS ANGELES- In a significant development impacting Missouri's cannabis industry, nearly one-quarter of the 48 social equity cannabis microbusiness permits awarded in October have been declared ineligible by the Department of Health and Senior Services (DHSS). The 11 affected applicants, encompassing permits for nine dispensaries and two wholesalers, face the loss of their licenses. This ...

December 19th, 2023|

Nebraska Medical Cannabis Initiative Gains Momentum Amid Opposition

LOS ANGELES- In Nebraska, a significant movement is underway as the group Nebraskans for Medical Marijuana (NMM) intensifies its efforts to gather signatures for two pivotal medical cannabis legalization initiatives aimed for the 2024 ballot. This drive highlights a growing grassroots movement in the state, reflecting a broader national dialogue on cannabis legalization. To secure ...

December 19th, 2023|

MindMed Announces Promising Results from Phase 2b Trial of MM-120 for Generalized Anxiety Disorder

LOS ANGELES- Mind Medicine (MindMed) Inc, a biotech company focusing on psychedelic-inspired therapies, recently revealed encouraging topline results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in treating Generalized Anxiety Disorder (GAD). The trial's success is significant, as it met its primary endpoint with MM-120 showing statistically significant improvements in anxiety symptoms compared ...

December 18th, 2023|

Sunstone Therapies Reports Breakthrough in Psilocybin-Assisted Therapy for Cancer Patients with Depression

LOS ANGELES- Sunstone Therapies, a organization in psychedelic-assisted therapy, recently announced notable findings from its phase 2 clinical trial, published in the journal Cancer. This trial marks a significant step in understanding the potential of psilocybin, a psychedelic compound, in treating major depressive disorder (MDD) among cancer patients. The study, an open-label trial, involved administering ...

December 18th, 2023|
Go to Top